世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035460

バイオマーカーの世界市場(2023-2027)

TechNavio

Global Biomarkers Market 2023-2027

発刊日 2023/05/22

言語英語

体裁PDF/157ページ

ライセンス/価格157ページ

0000035460

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

バイオマーカー市場は、2022年から2027年の間に562億6,785万米ドル成長し、予測期間中に13.05%のCAGRで加速すると予測されています。バイオマーカー市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。この市場は、心臓病の有病率の増加、ゲノミクスとプロテオミクスの進歩、バイオマーカーベースの診断法の開発への注目の高まりによって牽引されています。

バイオマーカー市場は次のように分類されます。

  • タイプ別
    ➣ 安全性
    ➣ 効能
    ➣ 検証
  • 用途別
    ➣ 創薬と開発
    ➣ 診断
    ➣ 個別 化医療
  • 地域別
    ➣ 北アメリカ
    ➣ ヨーロッパ
    ➣ アジア
    ➣ 世界のその他の地域

この調査は、研究開発プログラムと新製品発売の数の増加が、今後数年間のバイオマーカー市場の成長を促進する主な理由の1つであることを特定しています。また、新興経済国におけるバイオマーカー市場の成長と、医薬品開発や臨床試験におけるバイオマーカーの使用の増加により、市場での大きな需要が見込まれるでしょう。

バイオマーカー市場に関するレポートは、次の分野をカバーしています。

  • バイオマーカー市場の規模
  • バイオマーカー市場の予測
  • バイオマーカー市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、バイオマーカー市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

  • 調査企業
    ➣ Abbott Laboratories
    ➣ Agilent Technologies Inc.
    ➣ Becton Dickinson and Co.
    ➣ BG Medicine Inc.
    ➣ Bio Techne Corp.
    ➣ CENTOGENE NV
    ➣ Charles River Laboratories International Inc.
    ➣ EKF Diagnostics Holdings Plc
    ➣ Eurofins Scientific SE
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Meso Scale Diagnostics LLC
    ➣ Nexus Dx Inc.
    ➣ QIAGEN NV
    ➣ Siemens AG
    ➣ Thermo Fisher Scientific Inc.

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global biomarkers market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global biomarkers market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Safety - Market size and forecast 2022-2027
Exhibit 34: Chart on Safety - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Safety - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Safety - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Safety - Year-over-year growth 2022-2027 (%)
6.4 Efficacy - Market size and forecast 2022-2027
Exhibit 38: Chart on Efficacy - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Efficacy - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Efficacy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Efficacy - Year-over-year growth 2022-2027 (%)
6.5 Validation - Market size and forecast 2022-2027
Exhibit 42: Chart on Validation - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Validation - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Validation - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Validation - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ million)
Exhibit 47: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Application
7.1 Market segments
Exhibit 48: Chart on Application - Market share 2022-2027 (%)
Exhibit 49: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 50: Chart on Comparison by Application
Exhibit 51: Data Table on Comparison by Application
7.3 Drug discovery and development - Market size and forecast 2022-2027
Exhibit 52: Chart on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Drug discovery and development - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Drug discovery and development - Year-over-year growth 2022-2027 (%)
7.4 Diagnostics - Market size and forecast 2022-2027
Exhibit 56: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)
7.5 Personalized medicine - Market size and forecast 2022-2027
Exhibit 60: Chart on Personalized medicine - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Personalized medicine - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Personalized medicine - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Personalized medicine - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Application
Exhibit 64: Market opportunity by Application ($ million)
Exhibit 65: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
12.4 Agilent Technologies Inc.
Exhibit 120: Agilent Technologies Inc. - Overview
Exhibit 121: Agilent Technologies Inc. - Business segments
Exhibit 122: Agilent Technologies Inc. - Key offerings
Exhibit 123: Agilent Technologies Inc. - Segment focus
12.5 Becton Dickinson and Co.
Exhibit 124: Becton Dickinson and Co. - Overview
Exhibit 125: Becton Dickinson and Co. - Business segments
Exhibit 126: Becton Dickinson and Co. - Key news
Exhibit 127: Becton Dickinson and Co. - Key offerings
Exhibit 128: Becton Dickinson and Co. - Segment focus
12.6 BG Medicine Inc.
Exhibit 129: BG Medicine Inc. - Overview
Exhibit 130: BG Medicine Inc. - Product / Service
Exhibit 131: BG Medicine Inc. - Key offerings
12.7 Bio Techne Corp.
Exhibit 132: Bio Techne Corp. - Overview
Exhibit 133: Bio Techne Corp. - Business segments
Exhibit 134: Bio Techne Corp. - Key news
Exhibit 135: Bio Techne Corp. - Key offerings
Exhibit 136: Bio Techne Corp. - Segment focus
12.8 CENTOGENE NV
Exhibit 137: CENTOGENE NV - Overview
Exhibit 138: CENTOGENE NV - Product / Service
Exhibit 139: CENTOGENE NV - Key offerings
12.9 Charles River Laboratories International Inc.
Exhibit 140: Charles River Laboratories International Inc. - Overview
Exhibit 141: Charles River Laboratories International Inc. - Business segments
Exhibit 142: Charles River Laboratories International Inc. - Key news
Exhibit 143: Charles River Laboratories International Inc. - Key offerings
Exhibit 144: Charles River Laboratories International Inc. - Segment focus
12.10 EKF Diagnostics Holdings Plc
Exhibit 145: EKF Diagnostics Holdings Plc - Overview
Exhibit 146: EKF Diagnostics Holdings Plc - Business segments
Exhibit 147: EKF Diagnostics Holdings Plc - Key offerings
Exhibit 148: EKF Diagnostics Holdings Plc - Segment focus
12.11 Eurofins Scientific SE
Exhibit 149: Eurofins Scientific SE - Overview
Exhibit 150: Eurofins Scientific SE - Business segments
Exhibit 151: Eurofins Scientific SE - Key news
Exhibit 152: Eurofins Scientific SE - Key offerings
Exhibit 153: Eurofins Scientific SE - Segment focus
12.12 F. Hoffmann La Roche Ltd.
Exhibit 154: F. Hoffmann La Roche Ltd. - Overview
Exhibit 155: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 156: F. Hoffmann La Roche Ltd. - Key news
Exhibit 157: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 158: F. Hoffmann La Roche Ltd. - Segment focus
12.13 Meso Scale Diagnostics LLC
Exhibit 159: Meso Scale Diagnostics LLC - Overview
Exhibit 160: Meso Scale Diagnostics LLC - Product / Service
Exhibit 161: Meso Scale Diagnostics LLC - Key offerings
12.14 Nexus Dx Inc.
Exhibit 162: Nexus Dx Inc. - Overview
Exhibit 163: Nexus Dx Inc. - Product / Service
Exhibit 164: Nexus Dx Inc. - Key offerings
12.15 QIAGEN NV
Exhibit 165: QIAGEN NV - Overview
Exhibit 166: QIAGEN NV - Product / Service
Exhibit 167: QIAGEN NV - Key news
Exhibit 168: QIAGEN NV - Key offerings
12.16 Siemens AG
Exhibit 169: Siemens AG - Overview
Exhibit 170: Siemens AG - Business segments
Exhibit 171: Siemens AG - Key news
Exhibit 172: Siemens AG - Key offerings
Exhibit 173: Siemens AG - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 174: Thermo Fisher Scientific Inc. - Overview
Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
Exhibit 176: Thermo Fisher Scientific Inc. - Key news
Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 179: Inclusions checklist
Exhibit 180: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 181: Currency conversion rates for US$
13.4 Research methodology
Exhibit 182: Research methodology
Exhibit 183: Validation techniques employed for market sizing
Exhibit 184: Information sources
13.5 List of abbreviations
Exhibit 185: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global biomarkers market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Safety - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Safety - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Safety - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Safety - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Efficacy - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Efficacy - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Efficacy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Efficacy - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Validation - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Validation - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Validation - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Validation - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Type ($ million)
Exhibits47: Data Table on Market opportunity by Type ($ million)
Exhibits48: Chart on Application - Market share 2022-2027 (%)
Exhibits49: Data Table on Application - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Application
Exhibits51: Data Table on Comparison by Application
Exhibits52: Chart on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Drug discovery and development - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Drug discovery and development - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Personalized medicine - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Personalized medicine - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Personalized medicine - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Personalized medicine - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Application ($ million)
Exhibits65: Data Table on Market opportunity by Application ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key news
Exhibits118: Abbott Laboratories - Key offerings
Exhibits119: Abbott Laboratories - Segment focus
Exhibits120: Agilent Technologies Inc. - Overview
Exhibits121: Agilent Technologies Inc. - Business segments
Exhibits122: Agilent Technologies Inc. - Key offerings
Exhibits123: Agilent Technologies Inc. - Segment focus
Exhibits124: Becton Dickinson and Co. - Overview
Exhibits125: Becton Dickinson and Co. - Business segments
Exhibits126: Becton Dickinson and Co. - Key news
Exhibits127: Becton Dickinson and Co. - Key offerings
Exhibits128: Becton Dickinson and Co. - Segment focus
Exhibits129: BG Medicine Inc. - Overview
Exhibits130: BG Medicine Inc. - Product / Service
Exhibits131: BG Medicine Inc. - Key offerings
Exhibits132: Bio Techne Corp. - Overview
Exhibits133: Bio Techne Corp. - Business segments
Exhibits134: Bio Techne Corp. - Key news
Exhibits135: Bio Techne Corp. - Key offerings
Exhibits136: Bio Techne Corp. - Segment focus
Exhibits137: CENTOGENE NV - Overview
Exhibits138: CENTOGENE NV - Product / Service
Exhibits139: CENTOGENE NV - Key offerings
Exhibits140: Charles River Laboratories International Inc. - Overview
Exhibits141: Charles River Laboratories International Inc. - Business segments
Exhibits142: Charles River Laboratories International Inc. - Key news
Exhibits143: Charles River Laboratories International Inc. - Key offerings
Exhibits144: Charles River Laboratories International Inc. - Segment focus
Exhibits145: EKF Diagnostics Holdings Plc - Overview
Exhibits146: EKF Diagnostics Holdings Plc - Business segments
Exhibits147: EKF Diagnostics Holdings Plc - Key offerings
Exhibits148: EKF Diagnostics Holdings Plc - Segment focus
Exhibits149: Eurofins Scientific SE - Overview
Exhibits150: Eurofins Scientific SE - Business segments
Exhibits151: Eurofins Scientific SE - Key news
Exhibits152: Eurofins Scientific SE - Key offerings
Exhibits153: Eurofins Scientific SE - Segment focus
Exhibits154: F. Hoffmann La Roche Ltd. - Overview
Exhibits155: F. Hoffmann La Roche Ltd. - Business segments
Exhibits156: F. Hoffmann La Roche Ltd. - Key news
Exhibits157: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits158: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits159: Meso Scale Diagnostics LLC - Overview
Exhibits160: Meso Scale Diagnostics LLC - Product / Service
Exhibits161: Meso Scale Diagnostics LLC - Key offerings
Exhibits162: Nexus Dx Inc. - Overview
Exhibits163: Nexus Dx Inc. - Product / Service
Exhibits164: Nexus Dx Inc. - Key offerings
Exhibits165: QIAGEN NV - Overview
Exhibits166: QIAGEN NV - Product / Service
Exhibits167: QIAGEN NV - Key news
Exhibits168: QIAGEN NV - Key offerings
Exhibits169: Siemens AG - Overview
Exhibits170: Siemens AG - Business segments
Exhibits171: Siemens AG - Key news
Exhibits172: Siemens AG - Key offerings
Exhibits173: Siemens AG - Segment focus
Exhibits174: Thermo Fisher Scientific Inc. - Overview
Exhibits175: Thermo Fisher Scientific Inc. - Business segments
Exhibits176: Thermo Fisher Scientific Inc. - Key news
Exhibits177: Thermo Fisher Scientific Inc. - Key offerings
Exhibits178: Thermo Fisher Scientific Inc. - Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Validation techniques employed for market sizing
Exhibits184: Information sources
Exhibits185: List of abbreviations

この商品のレポートナンバー

0000035460

TOP